Percentage of CD39+ among CD4+ lymphocytes was equal to 8.56% ± 0.74% and to 11.35% ± 1.29% in healthy controls and ischemic stroke patients, respectively (p = 0.13, Figure 4a,b, Table 3). This evidence concerns the gene CD4 and ischemic stroke.